Nvidia, Eli Lilly plan AI drug innovation lab
Digest more
Eli Lilly’s presence in France has spanned more than six decades, but rumors of an acquisition suggest the pharmaceutical ...
Eli Lilly's research and development head said on Monday the company will have plenty of supply to launch its ...
Humana’s CenterWell pharmacy will dispense GLP-1 weight loss drugs made by Eli Lilly as part of a new program for employers ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2026 to 2030 based on projected revenue and net income.
Jan 8 () - Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic ...
Eli Lilly stock prepares €15B Abivax acquisition as tirzepatide revenue hits $24.8B. Orforglipron oral weight loss drug ...
It sounds like Lilly did just that. The U.S. pharma announced Wednesday that it was paying $14 per share of Ventyx—more than ...
Eli Lilly & Co. said Monday it expects its highly anticipated weight-loss pill to receive US regulatory approval as early as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback